Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Moderating Effects in Randomized Trials—Interpreting the P Value, Confidence Intervals, and Hazard Ratios

Kidney International Reports(2022)10.1016/j.ekir.2022.01.1049Source: DataRank Database

Moderating Effects in Randomized Trials—Interpreting the P Value, Confidence Intervals, and Hazard Ratios is a research paper published in Kidney International Reports (2022). On theSindex it has a DataRank of 0. It has been cited 5 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access5 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)OA: goldTopics (8)IDs (PubMed, PMC)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Brian S. Rifkin ORCID,Rajiv Agarwal ORCID

Live enrichment

PubMed:35257050 PMC:PMC8897672

National Institutes of Health

Grant: R01HL126903

U.S. Department of Veterans Affairs

Grant: 5I01CX001753

CSRD VA

Grant: I01 CX001753

National Institutes of Health

Grant: 5I01CX001753-05

Mechanisms of erythropoietin induced hypertension

National Institutes of Health

Grant: 5R01HL126903-04

ChLorthalidone In Chronic Kidney Disease (CLICK) Study

goldLicense: cc-by-nc-nd

publisherhttp://www.kireports.org/article/S2468024922010671/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2468024922010671?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2468024922010671?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8897672

repositoryhttps://doaj.org/article/10e5f5e3b39a442a93b36cbc3ae9acc6

Fields of Study

03 medical and health sciences0302 clinical medicine

Keywords

Blood pressureCommentaryAngiotensin-receptor blockersType 2 diabetesRC870-923Diseases of the genitourinary system. Urology

Moderating Effects in Randomized Trials—Interpreting the P Value, Confidence Intervals, and Hazard Ratios

FAIR Checklist

Authors (2)

Funding (5 grants)

Open Access

Topics

Annotations (Europe PMC)